Your eyes are getting heavy. You're getting sleepy. No hypnotist here, just APP Pharmaceuticals, a company that develops, makes, and markets anesthetics and other injectable drugs. Specializing in generics, APP's critical care products segment includes market-leading general anesthetic Diprivan and blood thinner Heparin. Other product segments focus on injectable oncology treatments and drugs that fight ear, heart, respiratory tract, skin, and sinus infections. APP markets through a direct sales force and often sells through group purchasing organizations to customers that include hospitals, long-term care facilities, and clinics in North America. In 2008 the company was acquired by Germany's Fresenius.

Key financials for APP Pharmaceuticals, LLC

Key people and executives for APP Pharmaceuticals, LLC

Top competitors of APP Pharmaceuticals, LLC

• Baxter International
• Hospira
• Teva Pharmaceuticals USA

View company events at APP Pharmaceuticals, LLC such as IPOs, bankruptcies, or executive changes

First Research Industry Profiles Extensive Industry Intelligence

• Pharmaceutical Manufacture and Sale
• Pharmaceuticals Manufacture

Hoover's Industries

• Pharmaceuticals
  • Pharmaceuticals Manufacturers
    • Generic Drugs(primary)
  • Biotechnology
    • Biopharmaceuticals & Biotherapeutics